Literature DB >> 12634413

Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells.

Fumihiko Nishimura1, Masahide Yoshikawa, Seiji Kanda, Masahiro Nonaka, Hiroshi Yokota, Akira Shiroi, Hiroyuki Nakase, Hidehiro Hirabayashi, Yukiteru Ouji, Jun-Ichi Birumachi, Shigeaki Ishizaka, Toshisuke Sakaki.   

Abstract

BACKGROUND: and Aims. The purpose of the present study was to examine the efficacy of transplantation of mouse embryonic-stem-(ES)-cell-derived tyrosine hydroxylase-positive (TH(+)) cells into Parkinsonian mice using behavioral tests and immunohistochemical evaluation.
METHODS: Undifferentiated ES cells carrying the enhanced green fluorescent protein (EGFP) gene were differentiated into a cell population containing TH(+) neurons using a five-step in vitro differentiation method. These ES-cell-derived cells were used as allografts in Parkinsonian mice, made by administering injections of 6-hydroxydopamine (6-OHDA). Fifteen hemiparkinsonian mice were divided into three groups. Four weeks after 6-OHDA injection, mice in groups 1, 2, and 3 received phosphate-buffered saline, 1 x 10(4) graft cells, and 1 x 10(5) graft cells, respectively, into their dopamine-denervated striata.
RESULTS: Improved rotational behavior was observed in the graft-transplanted groups (groups 2 and 3) 2 weeks after transplantation. Mice in group 2 displayed a continuous maintenance of reduced rotational behavior, while those in group 3 showed ipsilateral rotation toward the lesioned side at 4, 6, and 8 weeks after transplantation. Tumor formation was observed in one mouse in group 3. TH(+) cells were found at the grafted sites 8 weeks after transplantation in mice in groups 2 and 3, some of which were immunopositive to GFP, demonstrating the presence of dopaminergic neurons derived from the ES cells.
CONCLUSION: Transplantation of in vitro differentiated ES cells changed rotational behavior in Parkinsonian mice. Our results suggest the potential availability of ES cells for Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12634413     DOI: 10.1634/stemcells.21-2-171

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  18 in total

Review 1.  Thyroid stem cells: lessons from normal development and thyroid cancer.

Authors:  Dolly Thomas; Susan Friedman; Reigh-Yi Lin
Journal:  Endocr Relat Cancer       Date:  2008-03       Impact factor: 5.678

Review 2.  [Stem cells--cloning, plasticity, bioethic].

Authors:  Pamina Pflegerl; Thomas Keller; Brigitte Hantusch; Thomas Sören Hoffmann; Lukas Kenner
Journal:  Wien Med Wochenschr       Date:  2008

Review 3.  Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease.

Authors:  Yossef S Levy; Merav Stroomza; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

4.  Efficient generation of retinal progenitor cells from human embryonic stem cells.

Authors:  Deepak A Lamba; Mike O Karl; Carol B Ware; Thomas A Reh
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

5.  Embryonic stem cells develop into hepatocytes after intrasplenic transplantation in CCl4-treated mice.

Authors:  Kei Moriya; Masahide Yoshikawa; Ko Saito; Yukiteru Ouji; Mariko Nishiofuku; Noriko Hayashi; Shigeaki Ishizaka; Hiroshi Fukui
Journal:  World J Gastroenterol       Date:  2007-02-14       Impact factor: 5.742

6.  Promoted differentiation of cynomolgus monkey ES cells into hepatocyte-like cells by co-culture with mouse fetal liver-derived cells.

Authors:  Ko Saito; Masahide Yoshikawa; Yukiteru Ouji; Kei Moriya; Mariko Nishiofuku; Shigehiko Ueda; Noriko Hayashi; Shigeaki Ishizaka; Hiroshi Fukui
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

7.  Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant.

Authors:  L Hu; C McArthur; R B Jaffe
Journal:  Br J Cancer       Date:  2010-03-30       Impact factor: 7.640

8.  Directed differentiation of mouse embryonic stem cells into thyroid follicular cells.

Authors:  Maria C Arufe; Min Lu; Atsushi Kubo; Gordon Keller; Terry F Davies; Reigh-Yi Lin
Journal:  Endocrinology       Date:  2006-02-23       Impact factor: 4.736

Review 9.  Stem Cells in Neurological Disorders: Emerging Therapy with Stunning Hopes.

Authors:  Ghanshyam Upadhyay; Sharmila Shankar; Rakesh K Srivastava
Journal:  Mol Neurobiol       Date:  2014-09-23       Impact factor: 5.590

10.  Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype.

Authors:  Cecile Martinat; Jean-Jacques Bacci; Thomas Leete; Jongpil Kim; William B Vanti; Amy H Newman; Joo H Cha; Ulrik Gether; Honggang Wang; Asa Abeliovich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.